(Q44158827)

30 November 2017

title

The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels (English)

1 reference

30 November 2017

1 reference

Peter J Goadsby

1 reference

30 November 2017

Simon Akerman

1 reference

30 November 2017

Holger Kaube

1 reference

30 November 2017

David J Williamson

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

European Journal of Pharmacology

30 November 2017

published in

1 reference

30 November 2017

volume

452

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

223-228

1 reference

The effect of adrenergic compounds on neurogenic dural vasodilatation

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

K(+)-stimulated 45Ca2+ flux into rat neocortical mini-slices is blocked by omega-Aga-IVA and the dual Na+/Ca2+ channel blockers lidoflazine and flunarizine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Migraine--current understanding and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Nitroglycerin-Induced Headache is Not Dependent on Histamine Release: Support For a Direct Nociceptive Action of Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Flunarizine in migraine: a minireview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Nitric oxide is a key molecule in migraine and other vascular headaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Neurogenic inflammation in the context of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Sumatriptan Inhibits Neurogenic Vasodilation of Dural Blood Vessels in the Anaesthetized Rat—Intravital Microscope Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902307-5

10.1016/S0014-2999(02)02307-5

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference